Septicemia
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Magnolia Medical TechnologiesWA - Seattle
2 programsInitial Specimen Diversion DeviceN/A1 trial
Initial Specimen Diversion DeviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Magnolia Medical TechnologiesInitial Specimen Diversion Device
Magnolia Medical TechnologiesInitial Specimen Diversion Device
Clinical Trials (2)
Total enrollment: 1,171 patients across 2 trials
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device
Start: Jul 2014Est. completion: Oct 2015971 patients
N/ACompleted
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
Start: Jan 2014Est. completion: May 2015200 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space